Showing results (641-650 of 785) with videos related to
Sort By:
Pageof 79
Biorxiv : the Preprint Server for Biology|February 20, 2025
Histopathologic Evaluation and Single-Cell Spatial Transcriptomics of the Colon Reveal Cellular and Molecular Abnormalities Linked to J-Pouch Failure in Patients with Inflammatory Bowel DiseaseAndrea D Olivas, Paul Chak Mou Ngai, Emily Schahrer, et al.Journal of Gastroenterology and Hepatology|June 7, 2019
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remissionYunwei Wang, Jennifer Wang, Joel Pekow, et al.Digestive Diseases and Sciences|October 15, 2022
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical OutcomesNathaniel A Cohen, Joshua M Steinberg, Alexa Silfen, et al.Gastrointestinal Endoscopy|March 22, 2008
Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopyJuan M Herrerias, Jonathan A Leighton, Guido Costamagna, et al.Digestive Diseases and Sciences|February 9, 2018
Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective StudyDejan Micic, Andres Yarur, Alex Gonsalves, et al.Digestive Diseases and Sciences|August 24, 2018
Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective StudyDejan Micic, Andres Yarur, Alex Gonsalves, et al.Therapeutic Advances in Gastroenterology|September 11, 2023
Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitisOmar K Jamil, Dustin Shaw, Zifeng Deng, et al.Journal of Crohn'S & Colitis|July 4, 2023
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical ProgrammeStefan Schreiber, David T Rubin, Siew C Ng, et al.Inflammatory Bowel Diseases|February 22, 2017
Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative ColitisYong Huang, Sushila Dalal, Dionysios Antonopoulos, et al.Inflammatory Bowel Diseases|June 20, 2024
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical ProgramVipul Jairath, David T Rubin, Bram Verstockt, et al.Pageof 79